BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27240717)

  • 1. Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy.
    Dean JA; Wong KH; Welsh LC; Jones AB; Schick U; Newbold KL; Bhide SA; Harrington KJ; Nutting CM; Gulliford SL
    Radiother Oncol; 2016 Jul; 120(1):21-7. PubMed ID: 27240717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk.
    Dean JA; Welsh LC; Wong KH; Aleksic A; Dunne E; Islam MR; Patel A; Patel P; Petkar I; Phillips I; Sham J; Schick U; Newbold KL; Bhide SA; Harrington KJ; Nutting CM; Gulliford SL
    Clin Oncol (R Coll Radiol); 2017 Apr; 29(4):263-273. PubMed ID: 28057404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy.
    Dean J; Wong K; Gay H; Welsh L; Jones AB; Schick U; Oh JH; Apte A; Newbold K; Bhide S; Harrington K; Deasy J; Nutting C; Gulliford S
    Clin Transl Radiat Oncol; 2018 Jan; 8():27-39. PubMed ID: 29399642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy.
    Dean JA; Wong KH; Gay H; Welsh LC; Jones AB; Schick U; Oh JH; Apte A; Newbold KL; Bhide SA; Harrington KJ; Deasy JO; Nutting CM; Gulliford SL
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):820-831. PubMed ID: 27788955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study.
    Deneuve S; Bastogne T; Duclos M; Mirjolet C; Bois P; Bachmann P; Nokovitch L; Roux PE; Girodet D; Poupart M; Zrounba P; Claude L; Ferella L; Iacovelli NA; Foray N; Rancati T; Pereira S
    Tumori; 2023 Apr; 109(2):173-185. PubMed ID: 35578746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent external validation using the EORTC HNCG-ROG 1219 DAHANCA trial data of NTCP models for acute oral mucositis.
    Sharabiani M; Clementel E; Andratschke N; Collette L; Fortpied C; Grégoire V; Overgaard J; Willmann J; Hurkmans C
    Radiother Oncol; 2021 Aug; 161():35-39. PubMed ID: 33872641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiobiological modeling of radiation-induced acute mucosal toxicity (oral mucositis and pharyngeal mucositis): A single-institutional study of head-and-neck carcinoma.
    Singh B; Singh G; Oinam AS; Kumar V; Vashistha R; Sidhu MS; Singh M
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0-S1715. PubMed ID: 37147947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of radiation-induced mucositis of H&N cancer patients based on a large patient cohort.
    Hansen CR; Bertelsen A; Zukauskaite R; Johnsen L; Bernchou U; Thwaites DI; Eriksen JG; Johansen J; Brink C
    Radiother Oncol; 2020 Jun; 147():15-21. PubMed ID: 32224314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of programs to predict the occurrence of mucositis from digital imaging and communications in medicine data by machine learning in head and neck volumetric modulated radiotherapy.
    Rachi T; Ariji T; Takahashi S
    J Appl Clin Med Phys; 2023 Dec; 24(12):e14125. PubMed ID: 37602786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort.
    Blanchard P; Wong AJ; Gunn GB; Garden AS; Mohamed ASR; Rosenthal DI; Crutison J; Wu R; Zhang X; Zhu XR; Mohan R; Amin MV; Fuller CD; Frank SJ
    Radiother Oncol; 2016 Dec; 121(3):381-386. PubMed ID: 27641784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Oral Mucositis among Patients Undergoing Radiotherapy for Head and Neck Cancer: An Audit.
    Luitel A; Rimal J; Maharjan IK; Regmee P
    Kathmandu Univ Med J (KUMJ); 2019 Jan.-Mar; 17(65):61-65. PubMed ID: 31734681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature.
    Moslemi D; Nokhandani AM; Otaghsaraei MT; Moghadamnia Y; Kazemi S; Moghadamnia AA
    Radiother Oncol; 2016 Jul; 120(1):13-20. PubMed ID: 27113797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.
    Hong JP; Lee SW; Song SY; Ahn SD; Shin SS; Choi EK; Kim JH
    Eur J Cancer Care (Engl); 2009 Nov; 18(6):636-41. PubMed ID: 19456848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton therapy and oral mucositis in oral & oropharyngeal cancers: outcomes, dosimetric and NTCP benefit.
    Nangia S; Gaikwad U; Noufal MP; Sawant M; Wakde M; Mathew A; Chilukuri S; Sharma D; Jalali R
    Radiat Oncol; 2023 Jul; 18(1):121. PubMed ID: 37468950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: A double-blind placebo-controlled randomized clinical trial.
    Sheibani KM; Mafi AR; Moghaddam S; Taslimi F; Amiran A; Ameri A
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):22-7. PubMed ID: 25471468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
    Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
    Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy.
    Narayan S; Lehmann J; Coleman MA; Vaughan A; Yang CC; Enepekides D; Farwell G; Purdy JA; Laredo G; Nolan K; Pearson FS; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):756-62. PubMed ID: 18417299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.
    Deist TM; Dankers FJWM; Valdes G; Wijsman R; Hsu IC; Oberije C; Lustberg T; van Soest J; Hoebers F; Jochems A; El Naqa I; Wee L; Morin O; Raleigh DR; Bots W; Kaanders JH; Belderbos J; Kwint M; Solberg T; Monshouwer R; Bussink J; Dekker A; Lambin P
    Med Phys; 2018 Jul; 45(7):3449-3459. PubMed ID: 29763967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal Tissue Complication Probability Model for Acute Radiation Dermatitis in Patients With Head and Neck Cancer Treated With Carbon Ion Radiation Therapy.
    Li Y; Sakai M; Tsunoda A; Kubo N; Kitada Y; Kubota Y; Matsumura A; Zhou Y; Ohno T
    Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):675-684. PubMed ID: 35278673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.